Functional assessment and satisfaction of transfemoral amputees with low mobility (FASTK2): A clinical trial of microprocessor-controlled vs. non-microprocessor-controlled knees

Kenton R Kaufman, Kathie A. Bernhardt, Kevin Symms

Research output: Contribution to journalArticle

Abstract

Background: The benefits of a microprocessor-controlled knee are well documented in transfemoral amputees who are unlimited community ambulators. There have been suggestions that transfemoral amputees with limited community ambulation will also benefit from a microprocessor-controlled knee. Current medical policy restricts microprocessor-controlled knees to unlimited community ambulators and, thereby, potentially limits function. This clinical trial was performed to determine if limited community ambulators would benefit from a microprocessor-controlled knee. Methods: 50 unilateral transfemoral amputees, mean age 69, were tested using their current non-microprocessor-controlled knee, fit with a microprocessor-controlled knee and allowed 10 weeks of acclimation before being tested, and then retested with their original mechanical knee after 4 weeks of re-acclimation. Patient function was assessed in the free-living environment using tri-axial accelerometers. Patient satisfaction and safety were also measured. Findings: The subjects demonstrated improved outcomes when using the microprocessor-controlled knee. Subjects had a significant reduction in falls, spent less time sitting, and increased their activity level. Subjects also reported significantly better ambulation, improved appearance, and greater utility. Interpretation: This clinical trial demonstrated that transfemoral amputees with limited mobility clearly benefit from a microprocessor-controlled knee. Notably, a reduction in falls occurred while the subjects engaged in more physical activity, which resulted in increased subject satisfaction. The increased activity resulted in a greater exposure to fall risk, but that risk was moderated by the advanced technology. ClinicalTrials.gov No: NCT02240186

Original languageEnglish (US)
Pages (from-to)116-122
Number of pages7
JournalClinical Biomechanics
Volume58
DOIs
StatePublished - Oct 1 2018

Fingerprint

Amputees
Controlled Clinical Trials
Microcomputers
Knee
Acclimatization
Walking
Clinical Trials
Patient Safety
Patient Satisfaction
Exercise
Technology

Keywords

  • Amputees
  • Knee prosthesis
  • Locomotion
  • Microprocessor
  • Quality of life
  • Treatment outcome

ASJC Scopus subject areas

  • Biophysics
  • Orthopedics and Sports Medicine

Cite this

@article{829a4bf9f73f4fd88b043b78ca9eb0fe,
title = "Functional assessment and satisfaction of transfemoral amputees with low mobility (FASTK2): A clinical trial of microprocessor-controlled vs. non-microprocessor-controlled knees",
abstract = "Background: The benefits of a microprocessor-controlled knee are well documented in transfemoral amputees who are unlimited community ambulators. There have been suggestions that transfemoral amputees with limited community ambulation will also benefit from a microprocessor-controlled knee. Current medical policy restricts microprocessor-controlled knees to unlimited community ambulators and, thereby, potentially limits function. This clinical trial was performed to determine if limited community ambulators would benefit from a microprocessor-controlled knee. Methods: 50 unilateral transfemoral amputees, mean age 69, were tested using their current non-microprocessor-controlled knee, fit with a microprocessor-controlled knee and allowed 10 weeks of acclimation before being tested, and then retested with their original mechanical knee after 4 weeks of re-acclimation. Patient function was assessed in the free-living environment using tri-axial accelerometers. Patient satisfaction and safety were also measured. Findings: The subjects demonstrated improved outcomes when using the microprocessor-controlled knee. Subjects had a significant reduction in falls, spent less time sitting, and increased their activity level. Subjects also reported significantly better ambulation, improved appearance, and greater utility. Interpretation: This clinical trial demonstrated that transfemoral amputees with limited mobility clearly benefit from a microprocessor-controlled knee. Notably, a reduction in falls occurred while the subjects engaged in more physical activity, which resulted in increased subject satisfaction. The increased activity resulted in a greater exposure to fall risk, but that risk was moderated by the advanced technology. ClinicalTrials.gov No: NCT02240186",
keywords = "Amputees, Knee prosthesis, Locomotion, Microprocessor, Quality of life, Treatment outcome",
author = "Kaufman, {Kenton R} and Bernhardt, {Kathie A.} and Kevin Symms",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.clinbiomech.2018.07.012",
language = "English (US)",
volume = "58",
pages = "116--122",
journal = "Clinical Biomechanics",
issn = "0268-0033",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Functional assessment and satisfaction of transfemoral amputees with low mobility (FASTK2)

T2 - A clinical trial of microprocessor-controlled vs. non-microprocessor-controlled knees

AU - Kaufman, Kenton R

AU - Bernhardt, Kathie A.

AU - Symms, Kevin

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Background: The benefits of a microprocessor-controlled knee are well documented in transfemoral amputees who are unlimited community ambulators. There have been suggestions that transfemoral amputees with limited community ambulation will also benefit from a microprocessor-controlled knee. Current medical policy restricts microprocessor-controlled knees to unlimited community ambulators and, thereby, potentially limits function. This clinical trial was performed to determine if limited community ambulators would benefit from a microprocessor-controlled knee. Methods: 50 unilateral transfemoral amputees, mean age 69, were tested using their current non-microprocessor-controlled knee, fit with a microprocessor-controlled knee and allowed 10 weeks of acclimation before being tested, and then retested with their original mechanical knee after 4 weeks of re-acclimation. Patient function was assessed in the free-living environment using tri-axial accelerometers. Patient satisfaction and safety were also measured. Findings: The subjects demonstrated improved outcomes when using the microprocessor-controlled knee. Subjects had a significant reduction in falls, spent less time sitting, and increased their activity level. Subjects also reported significantly better ambulation, improved appearance, and greater utility. Interpretation: This clinical trial demonstrated that transfemoral amputees with limited mobility clearly benefit from a microprocessor-controlled knee. Notably, a reduction in falls occurred while the subjects engaged in more physical activity, which resulted in increased subject satisfaction. The increased activity resulted in a greater exposure to fall risk, but that risk was moderated by the advanced technology. ClinicalTrials.gov No: NCT02240186

AB - Background: The benefits of a microprocessor-controlled knee are well documented in transfemoral amputees who are unlimited community ambulators. There have been suggestions that transfemoral amputees with limited community ambulation will also benefit from a microprocessor-controlled knee. Current medical policy restricts microprocessor-controlled knees to unlimited community ambulators and, thereby, potentially limits function. This clinical trial was performed to determine if limited community ambulators would benefit from a microprocessor-controlled knee. Methods: 50 unilateral transfemoral amputees, mean age 69, were tested using their current non-microprocessor-controlled knee, fit with a microprocessor-controlled knee and allowed 10 weeks of acclimation before being tested, and then retested with their original mechanical knee after 4 weeks of re-acclimation. Patient function was assessed in the free-living environment using tri-axial accelerometers. Patient satisfaction and safety were also measured. Findings: The subjects demonstrated improved outcomes when using the microprocessor-controlled knee. Subjects had a significant reduction in falls, spent less time sitting, and increased their activity level. Subjects also reported significantly better ambulation, improved appearance, and greater utility. Interpretation: This clinical trial demonstrated that transfemoral amputees with limited mobility clearly benefit from a microprocessor-controlled knee. Notably, a reduction in falls occurred while the subjects engaged in more physical activity, which resulted in increased subject satisfaction. The increased activity resulted in a greater exposure to fall risk, but that risk was moderated by the advanced technology. ClinicalTrials.gov No: NCT02240186

KW - Amputees

KW - Knee prosthesis

KW - Locomotion

KW - Microprocessor

KW - Quality of life

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85050824109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050824109&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiomech.2018.07.012

DO - 10.1016/j.clinbiomech.2018.07.012

M3 - Article

C2 - 30077128

AN - SCOPUS:85050824109

VL - 58

SP - 116

EP - 122

JO - Clinical Biomechanics

JF - Clinical Biomechanics

SN - 0268-0033

ER -